Terms: = Skin cancer AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC
246 results:
1. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
[No Abstract] [Full Text] [Related]
2. Muir-Torre syndrome and recent updates on screening guidelines: The link between colorectal tumors and sebaceous adenomas in unusual locations.
Shaker N; Shaker N; Abid A; Shah S; Shakra RA; Sangueza OP
J Surg Oncol; 2023 Dec; 128(8):1380-1384. PubMed ID: 37706607
[TBL] [Abstract] [Full Text] [Related]
3. Histopathologic Features for Overall Survival in Merkel Cell Carcinoma: A Case Series with Intact Mismatch Repair Protein Expression.
Kestel S; Ogut B; Inan MA; Erdem O
Turk Patoloji Derg; 2023; 39(3):169-178. PubMed ID: 37350641
[TBL] [Abstract] [Full Text] [Related]
4. A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome.
Walker R; Mahmood K; Joo JE; Clendenning M; Georgeson P; Como J; Joseland S; Preston SG; Antill Y; Austin R; Boussioutas A; Bowman M; Burke J; Campbell A; Daneshvar S; Edwards E; Gleeson M; Goodwin A; Harris MT; Henderson A; Higgins M; Hopper JL; Hutchinson RA; Ip E; Isbister J; Kasem K; Marfan H; Milnes D; Ng A; Nichols C; O'Connell S; Pachter N; Pope BJ; Poplawski N; Ragunathan A; Smyth C; Spigelman A; Storey K; Susman R; Taylor JA; Warwick L; Wilding M; Williams R; Win AK; Walsh MD; Macrae FA; Jenkins MA; Rosty C; Winship IM; Buchanan DD;
J Transl Med; 2023 Apr; 21(1):282. PubMed ID: 37101184
[TBL] [Abstract] [Full Text] [Related]
5. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
Kovács SA; Fekete JT; Győrffy B
Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of clinicopathologic features, survival, and demographics in sebaceous carcinoma patients with and without Muir-Torre syndrome.
Maloney NJ; Zacher NC; Hirotsu KE; Rajan N; Aasi SZ; Kibbi N
J Am Acad Dermatol; 2023 Aug; 89(2):269-273. PubMed ID: 37003478
[TBL] [Abstract] [Full Text] [Related]
7. Clinical factors associated with skin neoplasms in individuals with Lynch syndrome in a longitudinal observational cohort.
Zhong CS; Horiguchi M; Uno H; Ukaegbu C; Chittenden A; LeBoeuf NR; Syngal S; Nambudiri VE; Yurgelun MB
J Am Acad Dermatol; 2023 Jun; 88(6):1282-1290. PubMed ID: 36773823
[TBL] [Abstract] [Full Text] [Related]
8. Molecular profiling of primary uveal melanoma: results of a Polish cohort.
Kowalik A; Karpinski P; Markiewicz A; Orlowska-Heitzman J; Romanowska-Dixon B; Donizy P; Hoang MP
Melanoma Res; 2023 Apr; 33(2):104-115. PubMed ID: 36719926
[TBL] [Abstract] [Full Text] [Related]
9. Deficient mismatch repair is detected in large-to-giant congenital melanocytic naevi: providing new insight into aetiology and diagnosis.
Wei B; Gu J; Gao B; Bao Y; Duan R; Li Q; Xie F
Br J Dermatol; 2023 Jan; 188(1):64-74. PubMed ID: 36689509
[TBL] [Abstract] [Full Text] [Related]
10. Liquid Biopsy as a Source of Nucleic Acid Biomarkers in the Diagnosis and Management of Lynch Syndrome.
Buglyó G; Styk J; Pös O; Csók Á; Repiska V; Soltész B; Szemes T; Nagy B
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457101
[TBL] [Abstract] [Full Text] [Related]
11. Lynch syndrome: An unusal case of familial cancer unearthed.
Dhar S; Mannan AU; Singh JJ; Dhar S; Pradhan S
Indian J Pathol Microbiol; 2022; 65(2):465-467. PubMed ID: 35435397
[TBL] [Abstract] [Full Text] [Related]
12. Expression of DNA mismatch repair proteins in melanoma patients treated with immune checkpoint inhibitors.
Gambichler T; Finis C; Abu Rached N; Scheel CH; Becker JC; Lang K; Käfferlein HU; Brüning T; Abolmaali N; Susok L
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1241-1247. PubMed ID: 35419731
[TBL] [Abstract] [Full Text] [Related]
13. Keratoacanthoma or cutaneous squamous cell carcinoma revealing a DNA mismatch repair default (Muir-Torre Syndrome).
Miao Y; Kolb F; Tomasic G; Lupu J; Routier E; Robert C
J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():74-76. PubMed ID: 34855250
[TBL] [Abstract] [Full Text] [Related]
14. Eruptive nevi in a patient with constitutional mismatch repair deficiency (CMMRD).
Vassantachart JM; Zacher NC; Teng JMC
Pediatr Dermatol; 2022 Jan; 39(1):91-93. PubMed ID: 34787334
[TBL] [Abstract] [Full Text] [Related]
15. Muir-Torre syndrome: a case of unusual coexisting genetic mutations.
Cino D; Drumm C; Sheahan K; D'Arcy C; Nolan N; Hoti E; Winter D; O'Duffy F; Dolan R; Moriarty B
Clin Exp Dermatol; 2022 Mar; 47(3):602-604. PubMed ID: 34762321
[TBL] [Abstract] [Full Text] [Related]
16. Mismatch Repair Protein Expression and Microsatellite Instability in Cutaneous Squamous Cell Carcinoma.
Gambichler T; Ganjuur N; Tannapfel A; Vogt M; Scholl L; Abu Rached N; Bruckmüller S; Skrygan M; Becker JC; Käfferlein HU; Brüning T; Lang K
Curr Oncol; 2021 Aug; 28(5):3316-3322. PubMed ID: 34590599
[TBL] [Abstract] [Full Text] [Related]
17. Mutational landscape in Uveal Melanoma.
Mastronikolis S; Adamopoulou M; Papouliakos S; Manoli A; Katsinis S; Makri O; Monastirioti AE; Tsiambas E; Georgakopoulos C
J BUON; 2021; 26(4):1194-1197. PubMed ID: 34564968
[TBL] [Abstract] [Full Text] [Related]
18. Molecular Genetics of Sebaceous Neoplasia.
North JP
Surg Pathol Clin; 2021 Jun; 14(2):273-284. PubMed ID: 34023105
[TBL] [Abstract] [Full Text] [Related]
19. A case of Muir-Torre syndrome with a keratoacanthoma and sebaceous neoplasms: Clinicopathological features and a speculation on the pathogenesis of cutaneous tumor type.
Takayama E; Yoshioka A; Takai T; Goto K
J Dermatol; 2021 May; 48(5):690-694. PubMed ID: 33523490
[TBL] [Abstract] [Full Text] [Related]
20. Pathology-based Biomarkers Useful for Clinical Decisions in Melanoma.
Torres-Cabala C; Li-Ning-Tapia E; Hwu WJ
Arch Med Res; 2020 Nov; 51(8):827-838. PubMed ID: 32950263
[TBL] [Abstract] [Full Text] [Related]
[Next]
